Title:
NOVEL DIAZABICYCLO DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2016/084866
Kind Code:
A1
Abstract:
Provided are: compounds having orexin receptor antagonistic effects; a pharmaceutical composition characterized by comprising the compounds as an active ingredient; and medical applications thereof, particularly prophylactic and/or therapeutic agents for diseases relating to orexin receptors, sleep disorders, mental disorders, neurodegenerative diseases, memory disorders and eating disorders, particularly sleep disorders such as insomnia. Specifically, provided are compounds represented by formula (I), or pharmaceutically acceptable salts thereof, or solvates thereof.
Inventors:
HOTTA DAIDO (JP)
SAKURADA ISAO (JP)
OGAWA KOUKI (JP)
SASANO KOTA (JP)
SAKURADA ISAO (JP)
OGAWA KOUKI (JP)
SASANO KOTA (JP)
Application Number:
PCT/JP2015/083128
Publication Date:
June 02, 2016
Filing Date:
November 25, 2015
Export Citation:
Assignee:
MOCHIDA PHARM CO LTD (JP)
International Classes:
C07D487/08; A61K31/4995; A61K31/506; A61K45/00; A61P25/20; A61P43/00; C07D519/00
Domestic Patent References:
| WO1999005121A1 | 1999-02-04 | |||
| WO2009132454A1 | 2009-11-05 | |||
| WO2008008517A2 | 2008-01-17 |
Foreign References:
| JPH08325254A | 1996-12-10 | |||
| FR2531709A1 | 1984-02-17 |
Other References:
ZIPP,G.G. ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 24, - 1 July 2014 (2014-07-01), pages 3886 - 3890
CAI,J. ET AL., EXPERT OPINION ON THERAPEUTIC PATENTS, vol. 16, no. 5, May 2006 (2006-05-01), pages 631 - 646
CAI,J. ET AL., EXPERT OPINION ON THERAPEUTIC PATENTS, vol. 16, no. 5, May 2006 (2006-05-01), pages 631 - 646
Attorney, Agent or Firm:
NISHIJIMA Takaki et al. (JP)
Takayoshi Nishijima (JP)
Takayoshi Nishijima (JP)
Download PDF:
Previous Patent: USER TERMINAL AND ACCESS POINT
Next Patent: SEEDLING-CUTTING APPARATUS, AND GRAFTING APPARATUS HAVING SEEDLING-CUTTING APPARATUS
Next Patent: SEEDLING-CUTTING APPARATUS, AND GRAFTING APPARATUS HAVING SEEDLING-CUTTING APPARATUS